YOLFTbeta
Axe Compute Inc.

Axe Compute Inc.

AGPU · NASDAQ · Technology / Software - Infrastructure

7.71USD-0.27 (-3.38%)

Price History

Full chart

Market Stats

Previous Close7.98
Open8.04
Day Range7.35 – 8.11
52-Week Range1.03 – 32.10
Volume207.00K
Market Cap131.56M
P/E (TTM)0.00
Forward P/E0.00
EPS-6.99
Dividend Yield0.00%
Beta3.49
50-Day Avg9.51
200-Day Avg6.11

About

Axe Compute Inc. provides access to graphics processing unit and digital asset treasury strategy. The company operates through two segments: Compute Services and Treasury Management; and Drug Discovery Services. The Compute Services and Treasury Management segment provides access to graphics processing unit compute capacity and digital asset treasury strategy focused on Aethir token. The Drug Discovery Services segment engages in the application of AI using its proprietary biobank of 150,000+ tumor samples, as well as creation of proprietary 3D culture models used in drug development. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.

Company Details

  • SectorTechnology
  • IndustrySoftware - Infrastructure
  • CEOMr. Christopher Miglino
  • Employees13
  • Headquarters91 43rd Street, Pittsburgh, PA, United States, 15201, USA
  • Websitehttps://axecompute.com

Leadership

  • Mr. Christopher MiglinoCEO & Director · b. 1969
  • Mr. Kyle OkamotoPresident
  • Mr. Jeremy Yaukey-WitterChief Financial Officer
  • Erin McMahonVice President of Marketing & Investor Relations
  • Ms. Sara Turken J.D.General Counsel
  • Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D.Senior Vice President of Biologics
  • Dr. Arlette H. Uihlein FCAP, M.D.Senior VP of Translational Medicine & Drug Discovery and Medical Director

Financials

Income Statement

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-15.74K28896.64K188.77K468.13K951.56K654.35K456.50K654.84K1.41M1.41M1.25M1.42M1.51M1.63M1.62M125.28K
Growth (%)---98.17%+33454.51%+95.34%+147.98%+103.27%-31.23%-30.24%+43.45%+115.57%-0.01%-11.28%+13.45%+5.97%+8.12%-0.24%-92.28%
Cost of Revenue5697.00K2.57K56.08K128.54K189.71K385.32K303.98K181.62K148.04K415.76K531.81K447.19K487.02K505.11K609.21K826.14K72.62K
Gross Profit-5698.74K-2.28K40.56K60.23K278.42K566.24K350.37K274.88K506.79K995.89K879.75K805.08K933.66K1.00M1.02M797.68K52.66K
Gross Margin-55.52%-792.01%41.97%31.91%59.48%59.51%53.54%60.21%77.39%70.55%62.32%64.29%65.72%66.45%62.57%49.12%42.03%
Operating Expense1.67M2.45M2.35M4.15M7.22M9.07M7.03M4.75M6.80M6.56M8.86M23.52M26.17M21.36M27.03M13.14M11.74M28.48M
Operating Income-1.67M-2.44M-2.35M-4.11M-7.16M-8.79M-6.47M-4.40M-6.53M-6.05M-7.86M-22.64M-25.36M-20.43M-26.03M-12.12M-10.94M-28.43M
Operating Margin--15528.05%-816287.50%-4248.26%-3792.77%-1877.02%-679.67%-672.36%-1429.59%-924.43%-556.89%-1604.23%-2025.12%-1437.95%-1729.28%-744.47%-673.69%-22688.58%
EBITDA-1.67M-2.81M-1.20M-4.25M-7.16M-8.76M-6.39M-4.32M-6.44M-5.98M-7.71M-13.07M-11.46M-12.13M-13.95M-11.77M-10.16M-232.17M
EBITDA Margin--17857.60%-417773.26%-4401.35%-3793.85%-1871.64%-671.82%-660.36%-1411.55%-913.51%-546.43%-925.90%-915.03%-853.91%-926.94%-723.28%-625.97%-185311.03%
Net Income-1.76M-2.89M-1.35M-4.49M-7.42M-9.41M-6.83M-4.79M-6.53M-6.00M-10.09M-19.39M-25.88M-19.66M-25.74M-13.98M-12.20M-233.10M
Net Income Margin--18378.53%-469690.63%-4643.02%-3931.81%-2009.36%-718.14%-732.10%-1429.59%-916.72%-714.51%-1373.71%-2066.99%-1383.65%-1709.62%-859.13%-751.39%-186053.45%
R&D----15.00K235.05K394.00K261.00K406.00K289.00K526.26K2.96M372.71K315.85K320.32K122.31K25.99K2.15M
R&D as % of Total Revenue----7.95%50.21%41.41%39.89%88.94%44.13%37.28%209.71%29.76%22.23%21.28%7.51%1.60%1713.88%
Interest Expense89.34K78.94K147.09K230.37K259.35K636.50K377.72K390.89K3-----10.65M---
Interest Expense % of Total Revenue-501.61%51073.96%238.39%137.39%135.97%39.69%59.74%0.00%-----707.44%---

Balance Sheet

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets788.98K290.30K165.87K446.22K369.58K593.43K900.98K5.63M2.81M3.62M3.71M22.38M13.06M43.77M25.73M14.42M4.97M52.89M
Total Liabilities1.10M2.63M2.36M3.15M3.67M3.81M6.42M1.52M1.88M932.34K3.66M11.14M10.42M3.51M3.97M6.15M5.18M5.17M
Total Equity-309.44K-2.34M-2.19M-2.70M-3.30M-3.22M-5.52M4.11M923.68K2.69M53.47K11.23M2.64M40.27M21.77M8.27M-202.61K47.72M
Cash463.84K16.63K9.38K122.98K13.14K101.95K16.38K4.86M1.76M766.19K162.15K150.83K678.33K28.20M22.07M8.73M734.67K10.79M
Total Debt296.03K189.73K1.07M1.69M1.17M280.00K937.42K---1.63M5.99M5.87M879.33K180.32K2.73M2.13M1.67M
Net Debt-167.81K173.10K1.06M1.56M1.16M178.05K921.04K-4.86M-1.76M-766.19K1.47M5.83M5.20M-27.32M-21.89M-6.00M1.40M-9.12M

Cash Flow

Currency: USD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-900.53K-1.31M-820.68K-1.78M-1.18M-3.86M-3.37M-7.49M-4.38M-4.46M-5.29M-8.73M-12.26M-12.21M-12.37M-13.19M-11.96M-9.96M
Investing Cash Flow-41.86K-----216.12K-121.24K-60.56K-422.86K-1.65M-1.11M-599.09K-167.46K-10.61M-475.70K-302.37K22.49K-31.99M
Financing Cash Flow1.40M862.78K813.43K1.90M1.07M4.16M3.41M12.39M1.71M5.11M5.79M9.32M12.95M50.34M6.72M148.90K3.94M52.01M
Capital Expenditure41.86K5005216.12K121.24K60.56K44.75K55.27K232.00K26.61K360.78K962.32K475.70K21.53K9.51K32.62M
Free Cash Flow-942.38K-1.31M-820.68K-1.78M-1.18M-4.07M-3.49M-7.55M-4.43M-4.52M-5.52M-8.76M-12.62M-13.17M-12.85M-13.21M-11.97M-42.49M
Dividends Paid---------------794--
FCF to OCF104.65%100.00%100.00%100.00%100.00%105.61%103.60%100.81%101.02%101.24%104.39%100.30%102.94%107.88%103.85%100.16%100.08%426.70%
Dividend Paid to FCF----------------0.01%--

Earnings

Report DateJun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Nov 15, 2016Dec 31, 2016May 15, 2017Aug 14, 2017Nov 14, 2017Dec 31, 2017Apr 2, 2018Aug 14, 2018Nov 14, 2018Dec 31, 2018Apr 1, 2019Aug 19, 2019Nov 15, 2019Dec 31, 2019Apr 1, 2020Aug 13, 2020Dec 2, 2020Mar 15, 2021May 12, 2021Aug 11, 2021Nov 10, 2021May 12, 2022Aug 11, 2022Nov 10, 2022Mar 21, 2023May 17, 2023Aug 11, 2023Nov 14, 2023Mar 29, 2024May 15, 2024Aug 14, 2024Nov 12, 2024Mar 31, 2025May 14, 2025Aug 13, 2025Nov 14, 2025May 18, 2026Aug 14, 2026Nov 13, 2026
EPS Estimate-------------------------------------------0.18-27.00-24.00-15.00-12.00-0.03-3.00-0.06-------4.80-3.75------
EPS Actual-21203.18-67583.11-174642.37-162192.47-96122.22-135091.42-687521.08-122847.53-219802.75-202137.59-138814.68-109632.12-54527.25-163527.53-79746.41-41114.87-43862.64-28026.17-58500.01-5162.05-27241.75-21272.22-32599.21-9020.00-2850.93-953.81-485.28-0.21-0.62-0.16-1304.38-0.43-0.20-0.19-733.66-0.230.02-1.31-1013.00-3.67-0.36-0.42-0.18-33.00-15.00-24.00-15.00-0.15-15.00-0.10-12.93-14.73-11.77-12.83-15.58-10.23-7.20-3.60-0.32-3.30-107.25-0.36-0.87-
Surprise------------------------------------------0.00%-22.22%37.50%-60.00%-25.00%-400.00%-400.00%-66.67%-------50.00%4.00%------
Timing-------------------------------------------After-hoursAfter-hoursAfter-hoursAfter-hours-After-hours-------After-hoursAfter-hours------

Key Statistics & Ratios

Market Cap131.56M
Enterprise Value111.77M
Trailing P/E0.00
Forward P/E0.00
Price / Sales40.32
Price / Book3.88
EPS-6.99
Book Value2.99
Revenue (TTM)3.26M
Gross Profit (TTM)237.12K
EBITDA-48.42M
Profit Margin0.00%
Operating Margin-538.97%
Return on Equity-1565.24%
Return on Assets-58.44%
Shares Outstanding11.59M
Shares Float11.24M
Beta3.49
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
3.91%
Insiders
5.96%
Retail / Other
90.13%

Top Institutional Holders

  • Diametric Capital, LP
    136.92K1.18%
  • Alpine Partners VI, LLC
    64.51K0.56%
  • Springbok Capital Management, LLC
    52.66K0.45%
  • Geode Capital Management, LLC
    46.69K0.40%
  • Vanguard Fiduciary Trust Co
    14.13K0.12%
  • Citadel Advisors Llc
    13.56K0.12%
  • UBS Group AG
    12.63K0.11%
  • Vanguard Capital Management, LLC
    10.57K0.09%
  • Bank of Montreal
    10.00K0.09%
  • Tower Research Capital LLC
    8950.01%
  • Carnegie Mellon University
    6910.01%
  • WOLFF WIESE MAGANA LLC
    2500.00%

Top Fund Holders

  • Abante Quant Value FI
    49.00K0.42%
  • Fidelity Extended Market Index
    20.92K0.18%
  • iShares Micro-Cap ETF
    17.73K0.15%
  • Fidelity Series Total Market Index
    7.26K0.06%
  • Fidelity Total Market Index
    6.85K0.06%
  • Fidelity Nasdaq Composite Index
    6.39K0.06%
  • 1290 VT Micro Cap K
    1.21K0.01%
  • Vanguard U.S. Eq Idx £ Acc
    960.00%

Stock Splits

  • Sep 30, 20251:15
  • Apr 24, 20231:20
  • Oct 29, 20191:10
  • Oct 28, 20161:25
  • Oct 28, 20141:75